PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.105 AUD
5%
Market Closed
Updated:
May 15, 2024
PYC Therapeutics Ltd
Selling, General & Administrative
|
PYC Therapeutics Ltd
Selling, General & Administrative Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Selling, General & Administrative
-AU$3.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-3%
|
|
|
Immutep Ltd
ASX:IMM
|
Selling, General & Administrative
-AU$9.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Selling, General & Administrative
-$23.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Selling, General & Administrative
-$2.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-11%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Selling, General & Administrative
-AU$42.1m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-21%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Selling, General & Administrative
-AU$133.9m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Selling, General & Administrative?
Selling, General & Administrative
-3.3m
AUD
-3.3m
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Selling, General & Administrative amounts to -3.3m AUD.
What is PYC Therapeutics Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-3%
-3%
Over the last year, the Selling, General & Administrative growth was 30%. The average annual Selling, General & Administrative growth rates for PYC Therapeutics Ltd have been 15% over the past three years , -28% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
